VytronUS, Inc. was formed in 2006 to harness the imaging and therapeutic capabilities of ultrasound energy to treat cardiac arrhythmias, starting with atrial fibrillation. We recognize that today's marketed technologies have limitations. Only a new energy source, such as collimated ultrasound, can shift the treatment paradigm to more predictable outcomes. We strive to make a complicated procedure simple. Ease of use guides every aspect of our design philosophy. At VytronUS, patient safety is always our first priority and improved efficacy is our mission. We look forward to making our products available to doctors and their patients in the near future.
Sunnyvale, US
VytronUS was founded in 2006 and is headquartered in Sunnyvale, US

VytronUS Office Locations

VytronUS has an office in Sunnyvale
Sunnyvale, US (HQ)
658 N Pastoria Ave

VytronUS Metrics

Summary Metrics

Founding Date


Total Funding

$115.4 m

Latest funding size

$49 m

Time since last funding

9 months


VytronUS's latest funding round in July 2016 was reported to be $49 m. In total, VytronUS has raised $115.4 m

VytronUS Company Life

You may also be interested in